Characteristics | No. (%) of partners | |
Cancer site |
| |
Breast | 51 | (46.8) |
Colorectal | 17 | (15.6) |
Stomach | 10 | (9.2) |
Other | 28 | (25.7) |
Missing/Unknown | 3 | (2.8) |
Cancer stage |
| |
0/I/II | 34 | (31.2) |
III/IV | 50 | (45.9) |
Missing/Unknown | 25 | (22.9) |
Disease status |
| |
First episode | 87 | (79.8) |
Metastases/recurrence | 14 | (12.8) |
Missing/Unknown | 8 | (7.3) |
Years since diagnosis |
| |
<1 | 56 | (51.4) |
≥1 and <5 | 38 | (34.9) |
≥5 | 13 | (11.9) |
Missing | 2 | (1.8) |
First treatment |
| |
Surgery | 60 | (55.0) |
Chemotherapy | 42 | (38.5) |
Others | 6 | (5.5) |
Missing/Unknown | 1 | (0.9) |
Treatment Type |
| |
Traditional chemotherapy | 54 | (49.5) |
Targeted therapy | 22 | (20.2) |
Traditional chemotherapy | 19 | (17.4) |
Plus targeted therapy |
| |
Missing/Unknown | 14 | (12.8) |
Duration of current treatment |
|
|
Median (IQR), month(s) | 3.0 | (0?9) |
Missing/Unknown | 7 | (6.4) |
Prior experience of chemotherapy |
| |
Yes | 41 | (37.6) |
No | 67 | (61.5) |
Missing | 1 | (0.9) |